Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC8024711/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC8024711/. The analysis below is for the second page.

Title[redir]:
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation - PMC
Description:
Sorafenib is a first-line molecular-target drug for advanced hepatocellular carcinoma (HCC), but its clinical effects are still limited. In this study we identify Quiescin sulfhydryl oxidase 1 (QSOX1) acting as a cellular pro-oxidant, specifically ...

Matching Content Categories {๐Ÿ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {๐Ÿ“}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of ncbi.nlm.nih.gov audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {๐Ÿ’ธ}

We can't see how the site brings in money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Ncbi.nlm.nih.gov has a revenue plan, but it's either invisible or we haven't found it.

Keywords {๐Ÿ”}

cells, qsox, nrf, hcc, doi, egfr, sorafenib, fig, levels, cell, tumor, expression, patients, pubmed, google, scholar, treatment, ferroptosis, signaling, tissues, antioxidant, usa, pmc, article, protein, compared, ros, activation, data, mhcchqsox, free, found, cancer, analysis, capacity, carcinoma, results, overexpression, egf, hepatocellular, death, rab, open, tab, control, knockdown, hepbshqsox, high, redox, nuclear,

Topics {โœ’๏ธ}

antioxidant n-acetyl-l-cysteine small-molecule multi-kinase inhibitors pleno-dce-puro vector cox-mantel log-rank test pleno-dce-puro-vehicle n-acetyl-l-cysteine p62-keap1-nrf2 pathway protects s-adenosyl homocysteine hydrolase ligand-induced endosomal transfer ligand-induced lysosomal degradation high-rank gene sets oxidative stress-induced damage p62/sqstm1 promotes malignancy formula lengthย ร—ย width2ย ร—ย ฯ€/6 pmc beta search goat anti-rabbit igg post-transcriptional control mechanism nrf2-dependent metabolic reprogramming small-cell lung cancers line molecular-target drug log2-transformed fold change nrf2-mediated cell proliferation promote sorafenib-induced ferroptosis promoting ubiquitination-mediated degradation egf-induced egfr signaling promoting sorafenib-induced ferroptosis sorafenib-induced lipid peroxidation ros-modulated coordinated regulation sorafenib-induced cell death canonical keap1-mediated regulation iron-dependent cell death epidermal growth factor drug-resistant mechanisms underlying hep3b/shqsox1 exhibited egfr-dependent tumor types publisher site pdf cancer-related processes hep3b/shqsox1 cell lines cancer-acquired drug resistance egfr/nrf2 signaling pathway hcv-positive hepatocellular carcinoma stimulate mhcc97h/qsox1 cells pro-oncogenic gene reactive oxygen species nadp+/nadph assay kit serum-free medium c-kit signaling resulting master transcriptional factor enhance sorafenib-induced ferroptosis hep3b/shqsox1 cells showed

Questions {โ“}

  • Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

External Links {๐Ÿ”—}(108)

Analytics and Tracking {๐Ÿ“Š}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {๐Ÿ“š}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {โœ‰๏ธ}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {๐Ÿ“ฆ}

  • Ncbi

3.8s.